Psychemedics

Psychemedics ROE

The Return on Equity (ROE) of Psychemedics (PMDI) as of Oct 16, 2026 is -36.28 %. In the previous year, Return on Equity (ROE) was -62.26 % — a change of -41.73% (higher).

ROE

-36.28 %

YoY

-41.73%

Last updated:

In 2024, Psychemedics's return on equity (ROE) was -36.28 %, a -41.73% increase from the -62.26 % ROE in the previous year.

The Psychemedics ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2017
32.87 USD
Jan 1, 2018
24.43 USD
Jan 1, 2019
9.16 USD
Jan 1, 2020
-30.84 USD
Jan 1, 2021
-5.43 USD
Jan 1, 2022
-10.06 USD
Jan 1, 2023
-62.26 USD
Jan 1, 2024
-36.28 USD
The Psychemedics ROE history
YEARROEYoY
-36.28 %-41.73%
-62.26 %+518.64%
-10.06 %+85.28%
-5.43 %-82.39%
-30.84 %-436.86%
9.16 %-62.52%
24.43 %-25.68%
32.87 %-23.19%
42.79 %+230.73%
12.94 %-48.24%
25.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp, trading under the ticker PMDI, is a U.S.-based company headquartered in Acton, Massachusetts. The company specializes in drug testing services, focusing on the analysis of hair samples to detect the presence of drugs of abuse. With 204 full-time employees, Psychemedics operates within the Health Care sector, specifically in the Health Care industry. The company's primary service involves conducting drug tests and reporting results to clients, including training for sample collection and storage of positive samples for a fee per unit tested. Its testing methodology provides detailed information on the approximate amount of drug ingested and historical data on drug use patterns over time. Psychemedics went public on January 22, 1987, marking the beginning of its journey as a publicly traded entity. The company's website, https://www.psychemedics.com/, serves as a primary source of information for its services and operations. While the company's core business is centered on drug testing, it does not disclose specific product names or additional services beyond the scope of hair sample analysis and reporting. Psychemedics maintains a presence in the U.S. market, with its operations primarily focused on providing reliable and detailed drug testing solutions to its clients. The company's approach to testing emphasizes both the immediate detection of drug use and the ability to track usage patterns over extended periods, offering a comprehensive service for its customers. Psychemedics is one of the most popular companies on Eulerpool.

ROE Details

Decoding Psychemedics's Return on Equity (ROE)

Psychemedics's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Psychemedics's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Psychemedics's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Psychemedics’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Psychemedics stock

Return on Equity (ROE) of Psychemedics is -36.28 % in 2024.

Return on Equity (ROE) of Psychemedics changed from -62.26 % to -36.28 %, representing a -41.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Psychemedics since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Psychemedics with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Psychemedics

All Key Metrics — Psychemedics